Groups | Pathways | Hits | Total | Percent | p value |
---|---|---|---|---|---|
Combination vs. control (p < 0.001) | MAPK signaling pathway | 42 | 271 | 15.5% | 0.0 |
 | TGF-beta signaling pathway | 17 | 85 | 20.0% | 0.0 |
 | Natural killer cell mediated cytotoxicity | 23 | 141 | 16.31% | 0.0 |
 | VEGF signaling pathway | 9 | 76 | 11.84% | 0.0147 |
 | Wnt signaling pathway | 18 | 151 | 11.92% | 7.0E-4 |
Combination vs. DAC (p < 0.05) | MAPK signaling pathway | 8 | 271 | 2.95% | 0.0318 |
 | p53 signaling pathway | 3 | 69 | 4.35% | 0.0689 |
 | TGF-beta signaling pathway | 4 | 85 | 4.71% | 0.0298 |
 | Wnt signaling pathway | 9 | 151 | 5.96% | 3.0E-4 |
Combination vs. IDA (p < 0.05) | MAPK signaling pathway | 21 | 271 | 7.75% | 8.0E-4 |
 | Natural killer cell mediated cytotoxicity | 19 | 141 | 13.48% | 0.0 |
 | p53 signaling pathway | 9 | 69 | 13.04% | 0.0011 |
 | PPAR signaling pathway | 7 | 69 | 10.14% | 0.0128 |
 | TGF-beta signaling pathway | 12 | 85 | 14.12% | 1.0E-4 |
 | Wnt signaling pathway | 16 | 151 | 10.6% | 1.0E-4 |